JBCHEPHARMPharmaceuticals
JB Chemicals & Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹2064.40
-1.97%
Current P/E38.54xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E49.4x22.1% below avg
⚠️
21.3% Premium to Industry
JBCHEPHARM P/E 38.54x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹41.56 | ₹1820 | 43.8x |
| 2024 | ₹34.85 | ₹1844 | 52.9x |
| 2023 | ₹26.17 | ₹1625 | 62.1x |
| 2022 | ₹24.91 | ₹972 | 39x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding JB Chemicals & Pharmaceuticals Ltd Valuation
JB Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) currently trades at 38.54x earnings. The Pharmaceuticals sector average PE is 31.77x. JBCHEPHARM commands a premium, reflecting high growth expectations. Historically, JBCHEPHARM has traded at an average PE of 49.4x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
20.12%
Dividend Yield
0.88%
More on JB Chemicals & Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.